Avalo Therapeutics, Inc. · NASDAQ:AVTX

Doyle Mittie had 1,084 Avalo Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Jun 10, 2026 · Filed Jun 12, 2026

On Jun 10, 2026, Doyle Mittie (Chief Medical Officer) had 1,084 Avalo Therapeutics, Inc. shares withheld for tax at US$13.10 for US$14,200, leaving 51,776 shares. Filed Jun 12, 2026 (Form 4).

Withheld for tax
1,084 shares
Price
US$13.10
Value
US$14,200
Holding after
51,776 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 10, 2026Common StockShares withheld for tax1,084US$13.1051,776Direct

Source

View original at SEC

Related